Alpha Family Trust’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,990
Closed -$474K 167
2024
Q2
$474K Hold
3,990
0.28% 59
2024
Q1
$425K Hold
3,990
0.26% 67
2023
Q4
$397K Buy
3,990
+1,640
+70% +$138K 0.27% 72
2023
Q3
$243K Buy
2,350
+525
+29% +$58.6K 0.18% 107
2023
Q2
$222K Sell
1,825
-365
-17% -$48.7K 0.15% 114
2023
Q1
$336K Hold
2,190
0.27% 71
2022
Q4
$393K Buy
+2,190
New +$358K 0.36% 53

Other funds holding MRNA

Alpha Family Trust's MRNA Position: Q3 2024 in Review

Alpha Family Trust sold out of Moderna (MRNA) in Q3 2024, closing a stake of 3,990 shares — an estimated $474K sold.

Alpha Family Trust first reported a position in MRNA in Q4 2022 and held it in 7 quarters. The position peaked at $474K in Q2 2024. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Alpha Family Trust reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Alpha Family Trust sold 3,990 Moderna shares in Q3 2024, an estimated $474K.
  • Alpha Family Trust first reported a position in Moderna in Q4 2022 and held it in 7 quarters.
  • Alpha Family Trust's Moderna position peaked at $474K in Q2 2024.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Alpha Family Trust's 13F filing for Q3 2024, filed 7 Nov 2024.